nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorambucil—Mucosal inflammation—Vandetanib—thyroid cancer	0.0296	0.0296	CcSEcCtD
Chlorambucil—Ureteric obstruction—Epirubicin—thyroid cancer	0.0249	0.0249	CcSEcCtD
Chlorambucil—Urine output—Epirubicin—thyroid cancer	0.0236	0.0236	CcSEcCtD
Chlorambucil—Interstitial lung disease—Vandetanib—thyroid cancer	0.0232	0.0232	CcSEcCtD
Chlorambucil—Ureteric obstruction—Doxorubicin—thyroid cancer	0.0231	0.0231	CcSEcCtD
Chlorambucil—Interstitial pneumonia—Sorafenib—thyroid cancer	0.0229	0.0229	CcSEcCtD
Chlorambucil—Nephrotic syndrome—Sorafenib—thyroid cancer	0.0229	0.0229	CcSEcCtD
Chlorambucil—Peripheral motor neuropathy—Epirubicin—thyroid cancer	0.0224	0.0224	CcSEcCtD
Chlorambucil—Urine output—Doxorubicin—thyroid cancer	0.0218	0.0218	CcSEcCtD
Chlorambucil—Lymphopenia—Sorafenib—thyroid cancer	0.0216	0.0216	CcSEcCtD
Chlorambucil—Metastatic neoplasm—Epirubicin—thyroid cancer	0.0213	0.0213	CcSEcCtD
Chlorambucil—Peripheral motor neuropathy—Doxorubicin—thyroid cancer	0.0207	0.0207	CcSEcCtD
Chlorambucil—Myelodysplastic syndrome—Epirubicin—thyroid cancer	0.0204	0.0204	CcSEcCtD
Chlorambucil—Mucosal inflammation—Sorafenib—thyroid cancer	0.02	0.02	CcSEcCtD
Chlorambucil—Metastatic neoplasm—Doxorubicin—thyroid cancer	0.0197	0.0197	CcSEcCtD
Chlorambucil—Myelodysplastic syndrome—Doxorubicin—thyroid cancer	0.0189	0.0189	CcSEcCtD
Chlorambucil—Cystitis noninfective—Vandetanib—thyroid cancer	0.016	0.016	CcSEcCtD
Chlorambucil—Cystitis—Vandetanib—thyroid cancer	0.0158	0.0158	CcSEcCtD
Chlorambucil—Interstitial lung disease—Sorafenib—thyroid cancer	0.0156	0.0156	CcSEcCtD
Chlorambucil—Neoplasm—Vandetanib—thyroid cancer	0.0148	0.0148	CcSEcCtD
Chlorambucil—Bladder pain—Vandetanib—thyroid cancer	0.0148	0.0148	CcSEcCtD
Chlorambucil—Neoplasm malignant—Sorafenib—thyroid cancer	0.013	0.013	CcSEcCtD
Chlorambucil—Mouth ulceration—Sorafenib—thyroid cancer	0.01	0.01	CcSEcCtD
Chlorambucil—Neoplasm—Sorafenib—thyroid cancer	0.01	0.01	CcSEcCtD
Chlorambucil—Neutropenia—Vandetanib—thyroid cancer	0.00963	0.00963	CcSEcCtD
Chlorambucil—Pneumonia—Vandetanib—thyroid cancer	0.00924	0.00924	CcSEcCtD
Chlorambucil—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.0091	0.0091	CcSEcCtD
Chlorambucil—Stomatitis—Vandetanib—thyroid cancer	0.00895	0.00895	CcSEcCtD
Chlorambucil—Renal failure acute—Sorafenib—thyroid cancer	0.00871	0.00871	CcSEcCtD
Chlorambucil—Lymphopenia—Epirubicin—thyroid cancer	0.008	0.008	CcSEcCtD
Chlorambucil—Erythema multiforme—Vandetanib—thyroid cancer	0.00779	0.00779	CcSEcCtD
Chlorambucil—Lymphopenia—Doxorubicin—thyroid cancer	0.0074	0.0074	CcSEcCtD
Chlorambucil—Mucosal inflammation—Epirubicin—thyroid cancer	0.00739	0.00739	CcSEcCtD
Chlorambucil—Alopecia—Vandetanib—thyroid cancer	0.00728	0.00728	CcSEcCtD
Chlorambucil—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.00724	0.00724	CcSEcCtD
Chlorambucil—Mucosal inflammation—Doxorubicin—thyroid cancer	0.00684	0.00684	CcSEcCtD
Chlorambucil—Febrile neutropenia—Epirubicin—thyroid cancer	0.0068	0.0068	CcSEcCtD
Chlorambucil—Tremor—Vandetanib—thyroid cancer	0.00672	0.00672	CcSEcCtD
Chlorambucil—Neutropenia—Sorafenib—thyroid cancer	0.0065	0.0065	CcSEcCtD
Chlorambucil—Febrile neutropenia—Doxorubicin—thyroid cancer	0.00629	0.00629	CcSEcCtD
Chlorambucil—Pneumonia—Sorafenib—thyroid cancer	0.00623	0.00623	CcSEcCtD
Chlorambucil—Convulsion—Vandetanib—thyroid cancer	0.00622	0.00622	CcSEcCtD
Chlorambucil—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.00614	0.00614	CcSEcCtD
Chlorambucil—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00607	0.00607	CcSEcCtD
Chlorambucil—Jaundice—Sorafenib—thyroid cancer	0.00604	0.00604	CcSEcCtD
Chlorambucil—Stomatitis—Sorafenib—thyroid cancer	0.00604	0.00604	CcSEcCtD
Chlorambucil—Infection—Vandetanib—thyroid cancer	0.00582	0.00582	CcSEcCtD
Chlorambucil—Thrombocytopenia—Vandetanib—thyroid cancer	0.00573	0.00573	CcSEcCtD
Chlorambucil—Dermatitis atopic—Epirubicin—thyroid cancer	0.00553	0.00553	CcSEcCtD
Chlorambucil—Neuritis—Epirubicin—thyroid cancer	0.00548	0.00548	CcSEcCtD
Chlorambucil—Erythema multiforme—Sorafenib—thyroid cancer	0.00526	0.00526	CcSEcCtD
Chlorambucil—Dyspepsia—Vandetanib—thyroid cancer	0.00515	0.00515	CcSEcCtD
Chlorambucil—Dermatitis atopic—Doxorubicin—thyroid cancer	0.00512	0.00512	CcSEcCtD
Chlorambucil—Decreased appetite—Vandetanib—thyroid cancer	0.00509	0.00509	CcSEcCtD
Chlorambucil—Neuritis—Doxorubicin—thyroid cancer	0.00507	0.00507	CcSEcCtD
Chlorambucil—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00506	0.00506	CcSEcCtD
Chlorambucil—Fatigue—Vandetanib—thyroid cancer	0.00505	0.00505	CcSEcCtD
Chlorambucil—Pain—Vandetanib—thyroid cancer	0.00501	0.00501	CcSEcCtD
Chlorambucil—Alopecia—Sorafenib—thyroid cancer	0.00491	0.00491	CcSEcCtD
Chlorambucil—Neoplasm malignant—Epirubicin—thyroid cancer	0.00479	0.00479	CcSEcCtD
Chlorambucil—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00479	0.00479	CcSEcCtD
Chlorambucil—Amenorrhoea—Epirubicin—thyroid cancer	0.00466	0.00466	CcSEcCtD
Chlorambucil—Abdominal pain—Vandetanib—thyroid cancer	0.00463	0.00463	CcSEcCtD
Chlorambucil—Body temperature increased—Vandetanib—thyroid cancer	0.00463	0.00463	CcSEcCtD
Chlorambucil—Anaemia—Sorafenib—thyroid cancer	0.00447	0.00447	CcSEcCtD
Chlorambucil—Neoplasm malignant—Doxorubicin—thyroid cancer	0.00443	0.00443	CcSEcCtD
Chlorambucil—Angioedema—Sorafenib—thyroid cancer	0.00442	0.00442	CcSEcCtD
Chlorambucil—Hyperuricaemia—Epirubicin—thyroid cancer	0.00441	0.00441	CcSEcCtD
Chlorambucil—Dyskinesia—Epirubicin—thyroid cancer	0.00435	0.00435	CcSEcCtD
Chlorambucil—Leukopenia—Sorafenib—thyroid cancer	0.00433	0.00433	CcSEcCtD
Chlorambucil—Amenorrhoea—Doxorubicin—thyroid cancer	0.00431	0.00431	CcSEcCtD
Chlorambucil—Asthenia—Vandetanib—thyroid cancer	0.0042	0.0042	CcSEcCtD
Chlorambucil—Blood uric acid increased—Epirubicin—thyroid cancer	0.00417	0.00417	CcSEcCtD
Chlorambucil—Pruritus—Vandetanib—thyroid cancer	0.00414	0.00414	CcSEcCtD
Chlorambucil—Hyperuricaemia—Doxorubicin—thyroid cancer	0.00408	0.00408	CcSEcCtD
Chlorambucil—Dyskinesia—Doxorubicin—thyroid cancer	0.00403	0.00403	CcSEcCtD
Chlorambucil—Diarrhoea—Vandetanib—thyroid cancer	0.00401	0.00401	CcSEcCtD
Chlorambucil—Cystitis noninfective—Epirubicin—thyroid cancer	0.004	0.004	CcSEcCtD
Chlorambucil—Cystitis—Epirubicin—thyroid cancer	0.00395	0.00395	CcSEcCtD
Chlorambucil—Infection—Sorafenib—thyroid cancer	0.00392	0.00392	CcSEcCtD
Chlorambucil—Thrombocytopenia—Sorafenib—thyroid cancer	0.00387	0.00387	CcSEcCtD
Chlorambucil—Blood uric acid increased—Doxorubicin—thyroid cancer	0.00386	0.00386	CcSEcCtD
Chlorambucil—Anorexia—Sorafenib—thyroid cancer	0.00377	0.00377	CcSEcCtD
Chlorambucil—Vomiting—Vandetanib—thyroid cancer	0.00372	0.00372	CcSEcCtD
Chlorambucil—Neoplasm—Epirubicin—thyroid cancer	0.0037	0.0037	CcSEcCtD
Chlorambucil—Mouth ulceration—Epirubicin—thyroid cancer	0.0037	0.0037	CcSEcCtD
Chlorambucil—Bladder pain—Epirubicin—thyroid cancer	0.0037	0.0037	CcSEcCtD
Chlorambucil—Cystitis noninfective—Doxorubicin—thyroid cancer	0.0037	0.0037	CcSEcCtD
Chlorambucil—Cystitis—Doxorubicin—thyroid cancer	0.00366	0.00366	CcSEcCtD
Chlorambucil—Lymphadenopathy—Epirubicin—thyroid cancer	0.00348	0.00348	CcSEcCtD
Chlorambucil—Nausea—Vandetanib—thyroid cancer	0.00348	0.00348	CcSEcCtD
Chlorambucil—Dyspepsia—Sorafenib—thyroid cancer	0.00348	0.00348	CcSEcCtD
Chlorambucil—Decreased appetite—Sorafenib—thyroid cancer	0.00343	0.00343	CcSEcCtD
Chlorambucil—Neoplasm—Doxorubicin—thyroid cancer	0.00342	0.00342	CcSEcCtD
Chlorambucil—Bladder pain—Doxorubicin—thyroid cancer	0.00342	0.00342	CcSEcCtD
Chlorambucil—Mouth ulceration—Doxorubicin—thyroid cancer	0.00342	0.00342	CcSEcCtD
Chlorambucil—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00341	0.00341	CcSEcCtD
Chlorambucil—Fatigue—Sorafenib—thyroid cancer	0.00341	0.00341	CcSEcCtD
Chlorambucil—Pain—Sorafenib—thyroid cancer	0.00338	0.00338	CcSEcCtD
Chlorambucil—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00323	0.00323	CcSEcCtD
Chlorambucil—Lymphadenopathy—Doxorubicin—thyroid cancer	0.00322	0.00322	CcSEcCtD
Chlorambucil—Renal failure acute—Epirubicin—thyroid cancer	0.00322	0.00322	CcSEcCtD
Chlorambucil—Urticaria—Sorafenib—thyroid cancer	0.00314	0.00314	CcSEcCtD
Chlorambucil—Abdominal pain—Sorafenib—thyroid cancer	0.00312	0.00312	CcSEcCtD
Chlorambucil—Body temperature increased—Sorafenib—thyroid cancer	0.00312	0.00312	CcSEcCtD
Chlorambucil—Renal failure acute—Doxorubicin—thyroid cancer	0.00298	0.00298	CcSEcCtD
Chlorambucil—Hypersensitivity—Sorafenib—thyroid cancer	0.00291	0.00291	CcSEcCtD
Chlorambucil—Asthenia—Sorafenib—thyroid cancer	0.00283	0.00283	CcSEcCtD
Chlorambucil—Pruritus—Sorafenib—thyroid cancer	0.00279	0.00279	CcSEcCtD
Chlorambucil—Ataxia—Epirubicin—thyroid cancer	0.00279	0.00279	CcSEcCtD
Chlorambucil—Diarrhoea—Sorafenib—thyroid cancer	0.0027	0.0027	CcSEcCtD
Chlorambucil—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00267	0.00267	CcSEcCtD
Chlorambucil—Ataxia—Doxorubicin—thyroid cancer	0.00258	0.00258	CcSEcCtD
Chlorambucil—Vomiting—Sorafenib—thyroid cancer	0.00251	0.00251	CcSEcCtD
Chlorambucil—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00247	0.00247	CcSEcCtD
Chlorambucil—Pancytopenia—Epirubicin—thyroid cancer	0.00244	0.00244	CcSEcCtD
Chlorambucil—Neutropenia—Epirubicin—thyroid cancer	0.0024	0.0024	CcSEcCtD
Chlorambucil—Nausea—Sorafenib—thyroid cancer	0.00235	0.00235	CcSEcCtD
Chlorambucil—Pneumonia—Epirubicin—thyroid cancer	0.0023	0.0023	CcSEcCtD
Chlorambucil—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00227	0.00227	CcSEcCtD
Chlorambucil—Pancytopenia—Doxorubicin—thyroid cancer	0.00226	0.00226	CcSEcCtD
Chlorambucil—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00224	0.00224	CcSEcCtD
Chlorambucil—Stomatitis—Epirubicin—thyroid cancer	0.00223	0.00223	CcSEcCtD
Chlorambucil—Jaundice—Epirubicin—thyroid cancer	0.00223	0.00223	CcSEcCtD
Chlorambucil—Neutropenia—Doxorubicin—thyroid cancer	0.00222	0.00222	CcSEcCtD
Chlorambucil—Pneumonia—Doxorubicin—thyroid cancer	0.00213	0.00213	CcSEcCtD
Chlorambucil—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.0021	0.0021	CcSEcCtD
Chlorambucil—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00208	0.00208	CcSEcCtD
Chlorambucil—Jaundice—Doxorubicin—thyroid cancer	0.00206	0.00206	CcSEcCtD
Chlorambucil—Stomatitis—Doxorubicin—thyroid cancer	0.00206	0.00206	CcSEcCtD
Chlorambucil—Erythema multiforme—Epirubicin—thyroid cancer	0.00194	0.00194	CcSEcCtD
Chlorambucil—Alopecia—Epirubicin—thyroid cancer	0.00182	0.00182	CcSEcCtD
Chlorambucil—Erythema multiforme—Doxorubicin—thyroid cancer	0.0018	0.0018	CcSEcCtD
Chlorambucil—Alopecia—Doxorubicin—thyroid cancer	0.00168	0.00168	CcSEcCtD
Chlorambucil—Anaemia—Epirubicin—thyroid cancer	0.00165	0.00165	CcSEcCtD
Chlorambucil—Agitation—Epirubicin—thyroid cancer	0.00164	0.00164	CcSEcCtD
Chlorambucil—Leukopenia—Epirubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Chlorambucil—Convulsion—Epirubicin—thyroid cancer	0.00155	0.00155	CcSEcCtD
Chlorambucil—Anaemia—Doxorubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Chlorambucil—Agitation—Doxorubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Chlorambucil—Leukopenia—Doxorubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Chlorambucil—Confusional state—Epirubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Chlorambucil—Infection—Epirubicin—thyroid cancer	0.00145	0.00145	CcSEcCtD
Chlorambucil—Convulsion—Doxorubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Chlorambucil—Thrombocytopenia—Epirubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Chlorambucil—Anorexia—Epirubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Chlorambucil—Confusional state—Doxorubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Chlorambucil—Infection—Doxorubicin—thyroid cancer	0.00134	0.00134	CcSEcCtD
Chlorambucil—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00132	0.00132	CcSEcCtD
Chlorambucil—Anorexia—Doxorubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Chlorambucil—Dyspepsia—Epirubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Chlorambucil—Decreased appetite—Epirubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Chlorambucil—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Chlorambucil—Fatigue—Epirubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Chlorambucil—Pain—Epirubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Chlorambucil—Feeling abnormal—Epirubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Chlorambucil—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Chlorambucil—Dyspepsia—Doxorubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Chlorambucil—Decreased appetite—Doxorubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Chlorambucil—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Chlorambucil—Fatigue—Doxorubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Chlorambucil—Urticaria—Epirubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Chlorambucil—Pain—Doxorubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Chlorambucil—Body temperature increased—Epirubicin—thyroid cancer	0.00115	0.00115	CcSEcCtD
Chlorambucil—Abdominal pain—Epirubicin—thyroid cancer	0.00115	0.00115	CcSEcCtD
Chlorambucil—Feeling abnormal—Doxorubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Chlorambucil—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Chlorambucil—Hypersensitivity—Epirubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Chlorambucil—Urticaria—Doxorubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Chlorambucil—Abdominal pain—Doxorubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Chlorambucil—Body temperature increased—Doxorubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Chlorambucil—Asthenia—Epirubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Chlorambucil—Pruritus—Epirubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Chlorambucil—Diarrhoea—Epirubicin—thyroid cancer	0.000999	0.000999	CcSEcCtD
Chlorambucil—Hypersensitivity—Doxorubicin—thyroid cancer	0.000995	0.000995	CcSEcCtD
Chlorambucil—Asthenia—Doxorubicin—thyroid cancer	0.000969	0.000969	CcSEcCtD
Chlorambucil—Pruritus—Doxorubicin—thyroid cancer	0.000956	0.000956	CcSEcCtD
Chlorambucil—Vomiting—Epirubicin—thyroid cancer	0.000928	0.000928	CcSEcCtD
Chlorambucil—Diarrhoea—Doxorubicin—thyroid cancer	0.000924	0.000924	CcSEcCtD
Chlorambucil—Nausea—Epirubicin—thyroid cancer	0.000867	0.000867	CcSEcCtD
Chlorambucil—Vomiting—Doxorubicin—thyroid cancer	0.000859	0.000859	CcSEcCtD
Chlorambucil—Nausea—Doxorubicin—thyroid cancer	0.000802	0.000802	CcSEcCtD
